How much change can patients cope with when it comes to their #drugdelivery device? According to Alex Fong, Head of Insight at Owen Mumford Pharmaceutical Services, we need to step away from assumptions on device interchangeability and find out what patients really want. Read more here: https://bit.ly/3zjTTkA
The Medicine Maker’s Post
More Relevant Posts
-
Have you ever wondered how drug prescription prices have become so costly, and why? Our very own Amar Lunagaria explains how the pharmacy benefits managers (PBM's) in the pharmaceutical world impacts the end user pricing that most of us see today, and how NiHowdy aims to leverage this position to lower prescription costs. #costfreeprescriptions #reshapingpharma #nihowdyrx
To view or add a comment, sign in
-
Finally, a company with a mission dedicated to helping everyday people, not just increasing shareholder value...
Have you ever wondered how drug prescription prices have become so costly, and why? Our very own Amar Lunagaria explains how the pharmacy benefits managers (PBM's) in the pharmaceutical world impacts the end user pricing that most of us see today, and how NiHowdy aims to leverage this position to lower prescription costs. #costfreeprescriptions #reshapingpharma #nihowdyrx
To view or add a comment, sign in
-
Explore the implications of the Biden Administration's negotiated Maximum Fair Prices (MFPs) in our crisp, informative article. Discover how these prices will affect the pharmaceutical industry, save the government significant sums, and set the stage for future drug pricing negotiations. https://pwc.to/3yXMLKD
To view or add a comment, sign in
-
-
Choosing the right container closure system (#CCS) format is crucial, so it's important to have a thorough understanding of the various components included in the CCS, their required function, storage temperature and conditions, and the overall administration of the drug product. West Pharmaceutical Services provides an overview: https://lnkd.in/eC_-wDYU
To view or add a comment, sign in
-
-
If you represent or support a pharmaceutical manufacturer, chances are good you’ve seen all the conversation around biosimilars heating up. In July alone, we saw an unprecedented number (seven!) of biosimilars for Humira launch simultaneously. Interestingly, though, if you look at the conversation going on in the marketplace, the bulk of the discussion about which will be adopted and why is focused on behind-the-scenes pricing. However, as many recent reports and our experience indicate, that’s not really what’s standing in the way of adoption.
In the ever-evolving pharmaceutical landscape, biosimilars are creating quite a buzz. But what's really hindering their adoption? SVP, Integrated Strategy Jennifer Kielmeyer Batey delves into the the three key challenges that manufacturers face in bringing biosimilars to the forefront in Med Ad News' latest article. Learn more: https://bit.ly/40Iu4Eh #Biosimilars #BiosimilarAdoption #Wondermore
To view or add a comment, sign in
-
-
The German health technology assessment of newly approved drugs aims to relate the declared added benefit with the pricing of pharmaceutical products. In our latest HTAQ article, our experts share how the outcome of the AMNOG benefit assessment affects reimbursement negotiations: https://ow.ly/NUES50S2j2q
To view or add a comment, sign in
-
-
Editor/Founder The Pharmaceutical Marketing Group - Executive Director at Clinician Burnout Foundation
Share your latest updates with ease! 📢 With The Guide of The Pharmaceutical Marketing Group, you can post important announcements directly on your listing. Keep your customers informed and engaged with real-time updates. Add your listing today: https://bit.ly/3pYKo1V #PharmaMarketing #BusinessSuccess #TheGuideTPMG #Announcements #BusinessGrowth"
To view or add a comment, sign in
-
-
Last month, we discussed developments in the US pharmaceutical distribution system. Now, we look at more current developments focusing on CVS Health, which is carving out a vertically integrated space at every level of pharmaceutical distribution. https://ow.ly/PV7850QphBh #intellusWW #WeAreIntellusWW #intellusYP #mrx #insights #HCinsights #IntellusMemberNews
To view or add a comment, sign in
-
-
Over 75% of patients have now accessed care virtually. As expectations for digital care continue to rise, #DirectToConsumer models should be top of mind for pharmaceutical manufacturers. Join our upcoming webinar on June 25 to hear from seasoned leaders on the current state of virtual care, and learn effective strategies to build a strong DTC model that exceeds patient expectations. Save your spot: https://lnkd.in/gNiRzZH4
To view or add a comment, sign in
-
-
Could it happen in #pharma? No more prior authorizations? Farewell to step-edits? Return of control of pricing to the patient/consumer? Sounds lovely, doesn’t it? Read William Roth's latest article to learn more about changes in drug distribution, pricing, access, and patient affordability.
Don't miss William Roth's thought-provoking series, Who Moved My Prescription? Part 4 in the Pharmaceutical Commerce Magazine: https://lnkd.in/eJTeUdij Who Moved My Prescription? Part 3: https://lnkd.in/eurdjurg Who Moved My Prescription? Part 2: https://lnkd.in/eMucaqTs Who Moved My Prescription? Part 1: https://lnkd.in/eZcdMgKn
To view or add a comment, sign in
-
Head of Market Insights
2moTrue words. Familiarity, trust, predictability, reassurance...all part of the equation when people consider or are presented with a change in injection device.